hMSC-mediated concurrent delivery of endostatin and carboxylesterase to mouse xenografts suppresses glioma initiation and recurrence.
about
Mesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunitiesMesenchymal stem cells as a vector for the inflammatory prostate microenvironmentAnti-angiogenic gene therapy in the treatment of malignant gliomasConditioned media from human adipose tissue-derived mesenchymal stem cells and umbilical cord-derived mesenchymal stem cells efficiently induced the apoptosis and differentiation in human glioma cell lines in vitroCurrent status of gene therapy for brain tumors.Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma.Applications of amniotic membrane and fluid in stem cell biology and regenerative medicine.AF-MSCs fate can be regulated by culture conditionsAntiangiogenic and anticancer molecules in cartilage.Convergence of gene and cell therapy.Human mesenchymal stem cells and their paracrine factors for the treatment of brain tumors.Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas.DEAD-box RNA helicase DDX23 modulates glioma malignancy via elevating miR-21 biogenesis.Clinically applicable human adipose tissue-derived mesenchymal stem cells delivering therapeutic genes to brainstem gliomas.Inflammatory Chemokines MIP-1δ and MIP-3α Are Involved in the Migration of Multipotent Mesenchymal Stromal Cells Induced by Hepatoma Cells.Therapeutic targeting of subdural medulloblastomas using human neural stem cells expressing carboxylesterase.Mesenchymal stem cells enhance tumorigenic properties of human glioblastoma through independent cell-cell communication mechanisms.
P2860
Q26799013-31C2702F-7212-4DE6-A62C-3C4ECF0A95B8Q26853374-2BCF6FAA-0BA7-4D3C-9BF9-8A3BB91880B3Q26866276-35F9B055-67FB-477A-A2CE-3B76D64DE0FBQ33757933-9241887E-5EC6-4AB3-9302-DAE43C311E27Q34318157-D2D4D491-7E62-47B4-9CD3-90593CBFA01BQ34381578-22974702-7D12-43BD-9B29-72E877902699Q36326880-812E32DD-3951-4148-BEC9-946E518FE403Q36890227-0148AF19-840A-4850-B782-ADC53CEE16C6Q38007565-4CFBB9BB-670A-4FD9-B728-121EA2D809F0Q38064950-296770B3-A329-479C-9C9F-930D64B7E846Q38139850-CE892711-CA14-4E6F-8048-66197A0A3E8EQ38715077-E4FEBF9D-42CB-480D-B462-DB3E59DAE53BQ38858984-88FD6A47-F9B7-4966-BADC-271024F408D5Q38869957-7A00DC65-10DD-4A5E-B54F-DD87C1C682D9Q38921024-794865CC-6060-456D-B313-443EC4BB737AQ44992838-16F05CBD-9156-43CF-9460-FBA985658647Q55379731-C1840806-7CDC-420B-B744-DE2180F75EB1
P2860
hMSC-mediated concurrent delivery of endostatin and carboxylesterase to mouse xenografts suppresses glioma initiation and recurrence.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
hMSC-mediated concurrent deliv ...... oma initiation and recurrence.
@ast
hMSC-mediated concurrent deliv ...... oma initiation and recurrence.
@en
type
label
hMSC-mediated concurrent deliv ...... oma initiation and recurrence.
@ast
hMSC-mediated concurrent deliv ...... oma initiation and recurrence.
@en
prefLabel
hMSC-mediated concurrent deliv ...... oma initiation and recurrence.
@ast
hMSC-mediated concurrent deliv ...... oma initiation and recurrence.
@en
P2093
P2860
P356
P1433
P1476
hMSC-mediated concurrent deliv ...... oma initiation and recurrence.
@en
P2093
Dachuan Piao
Do-Hyun Nam
Hyunggee Kim
Jai-Hee Moon
Jinlong Yin
Jun-Kyum Kim
Samuel Beck
Seungkwon You
Sung-Hak Kim
P2860
P304
P356
10.1038/MT.2011.28
P577
2011-03-08T00:00:00Z